Recorded Future Warns Neurotechnology Growth Could Increase Risks to Sensitive Data and Intellectual Property
Summary
Recorded Future warns that wider use of neurotechnology could increase risks of IP theft, data breaches, device disruption, and extortion as neurological and biometric data become more valuable and the attack surface expands.
Key points
- Consumer and enterprise adoption of neurotechnology could expand the attack surface for devices, data, and supporting apps and cloud services.
- Neurotechnology companies and research labs may face state-sponsored espionage, insider threats, and theft of valuable intellectual property.
- Brain and biometric data could be stolen for surveillance, intelligence gathering, targeted scams, or extortion.
- Device and software vulnerabilities could enable data access, inaccurate readings, or disruption that affects users and patients.
- The report cites a June 2026 breach notification from neuroscience company Glucobit concerning its Reframe app; the affected system and exposed data were not confirmed.
- Neurological data receives heightened protection under some EU and US privacy rules, but consumer wellness products may fall outside HIPAA coverage.
- Recorded Future recommends continuous monitoring, staff vetting and access controls, supplier security audits, and updated data governance.
Article Details
- Publisher
- Recorded Future
- Report Period
- As of June 2026
- Scope
- Emerging cyber, privacy, and national security risks to neurotechnology and neurological and biometric data.
- Key Statistics
- The global neurotechnology market is projected to reach $53 billion by 2034.
- A market study published in mid-2025 reported that 45 consumer neurotechnology brands focused on wellness and fitness emerged over the previous decade.
- Wearable-product shipments increased by 9.1% in 2025 compared with the previous year.
- As of June 2026, 31 vulnerabilities were recorded for biometric trackers; seven were rated critical.
- The 2015 Anthem hack affected nearly 80 million customers; the 2018 breach of Singapore’s largest healthcare provider affected 1.5 million patients.
- Recommendations
- Establish continuous monitoring, vetting, and data access controls to counter industrial espionage and malicious insiders.
- Audit external manufacturing partners, hardware vendors, and subsidized software ecosystems for risks of unauthorized data access.
- Review and update data governance frameworks to align with US national security bulk-data restrictions and EU GDPR protections for neurological data.
Threat Actors
Vendors
Alibaba GroupChinese wearables are integrated into a broader AI-enabled software ecosystem, such as Alibaba’s smart glasses, which support hands-free calling, music streaming, real-time language translation, e-commerce, navigation,GoogleEstablished technology companies such as Meta and Google are also investing in neurological and neurotechnology research.HuaweiThe Chinese government has subsidized wearable technology giants Xiaomi and Huawei, helping them become the top vendors worldwide in smartwatches and smart glasses.MetaEstablished technology companies such as Meta and Google are also investing in neurological and neurotechnology research.NeuracleWhile the US and Europe lead in the number of neurotech firms, the Chinese company Neuracle has produced the first BCI approved for commercial use.Recorded FutureFigure 1: Key threats in neurotechnology and how they will evolve (Source: Recorded Future)StrykerThe recent cyberattack against Stryker delayed some surgical procedures because the company was unable to deliver patient-specific products.XiaomiThe Chinese government has subsidized wearable technology giants Xiaomi and Huawei, helping them become the top vendors worldwide in smartwatches and smart glasses.
Products
Countries
ChinaChina and the United States (US) are engaged in strategic competition in neurotechnology development: The US leads in the number of neurotechnology firms, and brain-computer interface (BCI) research has been a long-termSingaporeAnthem hack (affecting nearly 80 million customers), the 2017 Equifax breach, and the 2018 breach of Singapore’s largest healthcare provider (affecting 1.5 million patients).United StatesChina and the United States (US) are engaged in strategic competition in neurotechnology development: The US leads in the number of neurotechnology firms, and brain-computer interface (BCI) research has been a long-term
Industries
Healthcarenearly 80 million customers), the 2017 Equifax breach, and the 2018 breach of Singapore’s largest healthcare provider (affecting 1.5 million patients).NeurotechnologyNeurotechnology is rapidly moving beyond clinical use cases, expanding the attack surface for sensitive neurological and biometric data: As adoption grows, larger volumes of brain activity, biometric, and behavioralTelecommunicationsMore recently, the Salt Typhoon campaign breached dozens of US telecommunications companies, though these attacks may have targeted specific individuals or critical national security systems.